| C410128 | 11,12-dihydroxyeicosatrienoic acid | "[Arsenites results in increased expression of and results in increased activity of EPHX2 protein] which results in increased abundance of 11,12-dihydroxyeicosatrienoic acid" | 22680237 |
| C410128 | 11,12-dihydroxyeicosatrienoic acid | "EPHX2 gene mutant form inhibits the reaction [Lipopolysaccharides results in increased abundance of 11,12-dihydroxyeicosatrienoic acid]" | 19896470 |
| C410128 | 11,12-dihydroxyeicosatrienoic acid | "EPHX2 gene mutant form promotes the reaction [[Lipopolysaccharides co-treated with Aspirin] results in decreased abundance of 11,12-dihydroxyeicosatrienoic acid]" | 19896470 |
| C410128 | 11,12-dihydroxyeicosatrienoic acid | "EPHX2 gene mutant form promotes the reaction [[Lipopolysaccharides co-treated with MK-886] results in decreased abundance of 11,12-dihydroxyeicosatrienoic acid]" | 19896470 |
| C410128 | 11,12-dihydroxyeicosatrienoic acid | "EPHX2 protein results in increased chemical synthesis of 11,12-dihydroxyeicosatrienoic acid" | 25377915 |
| C046783 | 11,12-epoxy-5,8,14-eicosatrienoic acid | "[Arsenites results in increased expression of and results in increased activity of EPHX2 protein] which results in decreased abundance of 11,12-epoxy-5,8,14-eicosatrienoic acid" | 22680237 |
| C046783 | 11,12-epoxy-5,8,14-eicosatrienoic acid | "EPHX2 gene mutant form results in increased abundance of 11,12-epoxy-5,8,14-eicosatrienoic acid" | 19896470 |
| C046783 | 11,12-epoxy-5,8,14-eicosatrienoic acid | "EPHX2 protein results in increased hydrolysis of 11,12-epoxy-5,8,14-eicosatrienoic acid" | 25377915 |
| C046783 | 11,12-epoxy-5,8,14-eicosatrienoic acid | "[Mercuric Chloride results in increased expression of and results in increased activity of EPHX2 protein] which results in decreased abundance of 11,12-epoxy-5,8,14-eicosatrienoic acid" | 24472606 |
| C561619 | 1-(1-methanesulfonylpiperidin-4-yl)-3-(4-trifluoromethoxyphenyl)urea | 1-(1-methanesulfonylpiperidin-4-yl)-3-(4-trifluoromethoxyphenyl)urea results in decreased activity of EPHX2 protein | 23576437 |
| C561619 | 1-(1-methanesulfonylpiperidin-4-yl)-3-(4-trifluoromethoxyphenyl)urea | 1-(1-methanesulfonylpiperidin-4-yl)-3-(4-trifluoromethoxyphenyl)urea inhibits the reaction [Dietary Fats inhibits the reaction [EPHX2 gene mutant form results in decreased phosphorylation of EIF2AK3 protein]] | 23576437 |
| C561619 | 1-(1-methanesulfonylpiperidin-4-yl)-3-(4-trifluoromethoxyphenyl)urea | 1-(1-methanesulfonylpiperidin-4-yl)-3-(4-trifluoromethoxyphenyl)urea results in decreased activity of EPHX2 protein | 23576437 |
| C561619 | 1-(1-methanesulfonylpiperidin-4-yl)-3-(4-trifluoromethoxyphenyl)urea | 1-(1-methanesulfonylpiperidin-4-yl)-3-(4-trifluoromethoxyphenyl)urea inhibits the reaction [Benzo(a)pyrene results in increased activity of EPHX2 protein] | 21383588 |
| C561619 | 1-(1-methanesulfonylpiperidin-4-yl)-3-(4-trifluoromethoxyphenyl)urea | 1-(1-methanesulfonylpiperidin-4-yl)-3-(4-trifluoromethoxyphenyl)urea results in decreased activity of EPHX2 protein | 21383588 |
| C504897 | 12-(3-adamantan-1-ylureido)dodecanoic acid | 12-(3-adamantan-1-ylureido)dodecanoic acid inhibits the reaction [TGFB1 protein results in increased expression of EPHX2 protein] | 28694203 |
| C504897 | 12-(3-adamantan-1-ylureido)dodecanoic acid | 12-(3-adamantan-1-ylureido)dodecanoic acid inhibits the reaction [EPHX2 gene results in decreased susceptibility to 2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine] | 23152114 |
| C504897 | 12-(3-adamantan-1-ylureido)dodecanoic acid | EPHX2 gene mutant form results in decreased susceptibility to 12-(3-adamantan-1-ylureido)dodecanoic acid | 23152114 |
| C107016 | 14,15-dihydroxyeicosatrienoic acid | "[Arsenites results in increased expression of and results in increased activity of EPHX2 protein] which results in increased abundance of 14,15-dihydroxyeicosatrienoic acid" | 22680237 |
| C107016 | 14,15-dihydroxyeicosatrienoic acid | "EPHX2 gene mutant form inhibits the reaction [Lipopolysaccharides results in increased abundance of 14,15-dihydroxyeicosatrienoic acid]" | 19896470 |
| C107016 | 14,15-dihydroxyeicosatrienoic acid | "EPHX2 gene mutant form promotes the reaction [[Lipopolysaccharides co-treated with Aspirin] results in decreased abundance of 14,15-dihydroxyeicosatrienoic acid]" | 19896470 |
| C107016 | 14,15-dihydroxyeicosatrienoic acid | "EPHX2 gene mutant form promotes the reaction [[Lipopolysaccharides co-treated with MK-886] results in decreased abundance of 14,15-dihydroxyeicosatrienoic acid]" | 19896470 |
| C494022 | 14,15-eicosa-5-enoic acid | "14,15-eicosa-5-enoic acid inhibits the reaction [EPHX2 gene mutant form results in increased susceptibility to 2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine]" | 23152114 |
| C046782 | 14,15-epoxy-5,8,11-eicosatrienoic acid | "[Arsenites results in increased expression of and results in increased activity of EPHX2 protein] which results in decreased abundance of 14,15-epoxy-5,8,11-eicosatrienoic acid" | 22680237 |
| C046782 | 14,15-epoxy-5,8,11-eicosatrienoic acid | "EPHX2 gene mutant form results in increased abundance of 14,15-epoxy-5,8,11-eicosatrienoic acid" | 19896470 |
| C046782 | 14,15-epoxy-5,8,11-eicosatrienoic acid | "[Mercuric Chloride results in increased expression of and results in increased activity of EPHX2 protein] which results in decreased abundance of 14,15-epoxy-5,8,11-eicosatrienoic acid" | 24472606 |
| C025984 | 15-hydroxy-5,8,11,13-eicosatetraenoic acid | "15-hydroxy-5,8,11,13-eicosatetraenoic acid results in increased activity of EPHX2 protein" | 25600587 |
| C028108 | 16 alpha,17-epoxyprogesterone | "16 alpha,17-epoxyprogesterone inhibits the reaction [EPHX2 protein results in increased metabolism of stilbene oxide analog]" | 2043152 |
| C066841 | 2,3,7,8-tetrabromodibenzo-4-dioxin | "2,3,7,8-tetrabromodibenzo-4-dioxin results in increased expression of EPHX2 protein" | 27604104 |
| C061282 | 2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine | 12-(3-adamantan-1-ylureido)dodecanoic acid inhibits the reaction [EPHX2 gene results in decreased susceptibility to 2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine] | 23152114 |
| C061282 | 2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine | "14,15-eicosa-5-enoic acid inhibits the reaction [EPHX2 gene mutant form results in increased susceptibility to 2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine]" | 23152114 |
| C061282 | 2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine | 4-(4-(3-adamantan-1-ylureido)cyclohexyloxy)benzoic acid inhibits the reaction [EPHX2 gene results in decreased susceptibility to 2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine] | 23152114 |
| C061282 | 2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine | EPHX2 gene mutant form results in increased susceptibility to 2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine | 23152114 |
| C061282 | 2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine | EPHX2 gene results in decreased susceptibility to 2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine | 23152114 |
| C061282 | 2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine | T 0070907 inhibits the reaction [EPHX2 gene mutant form results in increased susceptibility to 2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine] | 23152114 |
| C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | "[Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in increased expression of EPHX2 mRNA" | 28433925 |
| C425784 | 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole | 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole results in decreased expression of EPHX2 mRNA | 25781201 |
| C572491 | 3-(2-hydroxy-4-(2-methylnonan-2-yl)phenyl)cyclohexan-1-ol | 3-(2-hydroxy-4-(2-methylnonan-2-yl)phenyl)cyclohexan-1-ol results in increased expression of EPHX2 protein | 26194647 |
| C028451 | 3,4,3',4'-tetrachlorobiphenyl | "3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of EPHX2 mRNA]" | 19467301 |
| C023035 | 3,4,5,3',4'-pentachlorobiphenyl | "3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of EPHX2 mRNA" | 23196670 |
| C473484 | 4-(2-bromo-6-pyrrolidin-1-ylpyridine-4-sulfonyl)phenylamine | 4-(2-bromo-6-pyrrolidin-1-ylpyridine-4-sulfonyl)phenylamine affects the expression of EPHX2 mRNA | 14610520 |
| C575631 | 4-(4-(2,4-dioxothiazolidin-5-ylidenemethyl)-2-methoxyphenoxy)-3-trifluoromethylbenzonitrile | "4-(4-(2,4-dioxothiazolidin-5-ylidenemethyl)-2-methoxyphenoxy)-3-trifluoromethylbenzonitrile affects the expression of EPHX2 mRNA" | 21218783 |
| C572961 | 4-(4-(3-(4-trifluoromethoxy-phenyl)ureido)cyclohexyloxy)benzoic acid | 4-(4-(3-(4-trifluoromethoxy-phenyl)ureido)cyclohexyloxy)benzoic acid results in decreased activity of EPHX2 protein | 25377915 |
| C524106 | 4-(4-(3-adamantan-1-ylureido)cyclohexyloxy)benzoic acid | 4-(4-(3-adamantan-1-ylureido)cyclohexyloxy)benzoic acid inhibits the reaction [EPHX2 gene results in decreased susceptibility to 2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine] | 23152114 |
| C524106 | 4-(4-(3-adamantan-1-ylureido)cyclohexyloxy)benzoic acid | 4-(4-(3-adamantan-1-ylureido)cyclohexyloxy)benzoic acid results in increased expression of EPHX2 protein | 25724490 |
| C524106 | 4-(4-(3-adamantan-1-ylureido)cyclohexyloxy)benzoic acid | EPHX2 gene mutant form results in decreased susceptibility to 4-(4-(3-adamantan-1-ylureido)cyclohexyloxy)benzoic acid | 23152114 |
| C524106 | 4-(4-(3-adamantan-1-ylureido)cyclohexyloxy)benzoic acid | 4-(4-(3-adamantan-1-ylureido)cyclohexyloxy)benzoic acid results in decreased activity of EPHX2 protein | 21398593|2361154 |
| C009505 | 4,4'-diaminodiphenylmethane | "4,4'-diaminodiphenylmethane results in decreased expression of EPHX2 mRNA" | 18648102 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EPHX2 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EPHX2 mRNA" | 27188386 |
| C071863 | 4-fluorochalcone oxide | 4-fluorochalcone oxide results in decreased activity of EPHX2 protein | 1500033 |
| C040776 | 5,6-epoxy-8,11,14-eicosatrienoic acid | "EPHX2 gene mutant form results in increased abundance of 5,6-epoxy-8,11,14-eicosatrienoic acid" | 19896470 |
| C022022 | 5-hydroxy-6,8,11,14-eicosatetraenoic acid | "5-hydroxy-6,8,11,14-eicosatetraenoic acid results in increased activity of EPHX2 protein" | 25600587 |
| C022022 | 5-hydroxy-6,8,11,14-eicosatetraenoic acid | "EPHX2 gene mutant form promotes the reaction [MK-886 inhibits the reaction [Lipopolysaccharides results in increased abundance of 5-hydroxy-6,8,11,14-eicosatetraenoic acid]]" | 19896470 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EPHX2 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EPHX2 mRNA" | 27188386 |
| C050715 | 8,9-epoxyeicosatrienoic acid | "EPHX2 gene mutant form results in increased abundance of 8,9-epoxyeicosatrienoic acid" | 19896470 |
| D000082 | Acetaminophen | Acetaminophen results in decreased expression of EPHX2 mRNA | 29067470 |
| D000082 | Acetaminophen | [Clofibrate co-treated with Acetaminophen] affects the expression of EPHX2 mRNA | 17585979 |
| D000082 | Acetaminophen | PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of EPHX2 mRNA] | 17585979 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 affects the expression of EPHX2 protein | 20106945 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 results in decreased expression of EPHX2 mRNA | 22100608|2715375 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 results in decreased methylation of EPHX2 gene | 27153756 |
| D000393 | Air Pollutants | Air Pollutants analog results in decreased expression of EPHX2 mRNA | 21757418 |
| D000643 | Ammonium Chloride | Ammonium Chloride affects the expression of EPHX2 mRNA | 16483693 |
| D016718 | Arachidonic Acid | EPHX2 protein results in increased metabolism of Arachidonic Acid | 26165641 |
| C006632 | arsenic trioxide | arsenic trioxide results in increased expression of EPHX2 mRNA | 17530438 |
| C015001 | arsenite | arsenite results in increased expression of EPHX2 mRNA | 18929588 |
| D018053 | Arsenites | Arsenites results in increased expression of and results in increased activity of EPHX2 protein | 22680237 |
| D018053 | Arsenites | "[Arsenites results in increased expression of and results in increased activity of EPHX2 protein] which results in decreased abundance of 11,12-epoxy-5,8,14-eicosatrienoic acid" | 22680237 |
| D018053 | Arsenites | "[Arsenites results in increased expression of and results in increased activity of EPHX2 protein] which results in decreased abundance of 14,15-epoxy-5,8,11-eicosatrienoic acid" | 22680237 |
| D018053 | Arsenites | "[Arsenites results in increased expression of and results in increased activity of EPHX2 protein] which results in increased abundance of 11,12-dihydroxyeicosatrienoic acid" | 22680237 |
| D018053 | Arsenites | "[Arsenites results in increased expression of and results in increased activity of EPHX2 protein] which results in increased abundance of 14,15-dihydroxyeicosatrienoic acid" | 22680237 |
| D018053 | Arsenites | "[Arsenites results in increased expression of and results in increased activity of EPHX2 protein] which results in increased abundance of eicosa-5,11,14-trienoic acid analog" | 22680237 |
| D018053 | Arsenites | Arsenites results in increased expression of EPHX2 mRNA | 22680237 |
| D017636 | Asbestos, Amphibole | "Asbestos, Amphibole affects the expression of EPHX2 protein" | 20855422 |
| D001205 | Ascorbic Acid | [Quercetin co-treated with Ascorbic Acid] results in decreased expression of EPHX2 mRNA | 17639512 |
| D001241 | Aspirin | Aspirin promotes the reaction [EPHX2 gene mutant form results in decreased susceptibility to Lipopolysaccharides] | 19896470 |
| D001241 | Aspirin | EPHX2 gene mutant form promotes the reaction [Aspirin inhibits the reaction [Lipopolysaccharides results in increased abundance of Dinoprostone]] | 19896470 |
| D001241 | Aspirin | EPHX2 gene mutant form promotes the reaction [Aspirin inhibits the reaction [Lipopolysaccharides results in increased abundance of Prostaglandin D2]] | 19896470 |
| D001241 | Aspirin | "EPHX2 gene mutant form promotes the reaction [[Lipopolysaccharides co-treated with Aspirin] results in decreased abundance of 11,12-dihydroxyeicosatrienoic acid]" | 19896470 |
| D001241 | Aspirin | "EPHX2 gene mutant form promotes the reaction [[Lipopolysaccharides co-treated with Aspirin] results in decreased abundance of 14,15-dihydroxyeicosatrienoic acid]" | 19896470 |
| C547126 | AZM551248 | AZM551248 results in decreased expression of EPHX2 mRNA | 22323515 |
| C006697 | benzil | benzil results in decreased activity of EPHX2 protein | 3621371 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of EPHX2 mRNA | 20106945|2231617 |
| D001564 | Benzo(a)pyrene | 1-(1-methanesulfonylpiperidin-4-yl)-3-(4-trifluoromethoxyphenyl)urea inhibits the reaction [Benzo(a)pyrene results in increased activity of EPHX2 protein] | 21383588 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased activity of EPHX2 protein | 22051199 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased activity of EPHX2 protein | 19889059|2138358 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of EPHX2 mRNA | 19889059|2138358 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of EPHX2 protein | 19889059 |
| D001564 | Benzo(a)pyrene | Glycyrrhizic Acid inhibits the reaction [Benzo(a)pyrene results in decreased activity of EPHX2 protein] | 22051199 |
| C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of EPHX2 mRNA | 20061341 |
| C095105 | bexarotene | bexarotene results in increased expression of EPHX2 mRNA | 23292798 |
| C006780 | bisphenol A | bisphenol A affects the expression of EPHX2 mRNA | 21786754 |
| C006780 | bisphenol A | "[Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in increased expression of EPHX2 mRNA" | 28433925 |
| C006780 | bisphenol A | bisphenol A results in decreased expression of EPHX2 mRNA | 25181051 |
| C006780 | bisphenol A | bisphenol A results in increased methylation of EPHX2 gene | 28505145 |
| D002083 | Butylated Hydroxyanisole | Butylated Hydroxyanisole results in decreased expression of EPHX2 protein | 3621371 |
| D002083 | Butylated Hydroxyanisole | Butylated Hydroxyanisole results in increased activity of EPHX2 protein | 3621371 |
| D020122 | tert-Butylhydroperoxide | tert-Butylhydroperoxide results in increased expression of EPHX2 mRNA | 14729362 |
| C028031 | cadmium acetate | cadmium acetate affects the expression of EPHX2 mRNA | 16249259 |
| D019256 | Cadmium Chloride | Cadmium Chloride results in decreased expression of EPHX2 mRNA | 20061341 |
| D019256 | Cadmium Chloride | Cadmium Chloride results in decreased expression of EPHX2 mRNA | 25993096 |
| D002118 | Calcium | Calcium affects the expression of EPHX2 mRNA | 15913539 |
| D002220 | Carbamazepine | Carbamazepine results in decreased expression of EPHX2 mRNA | 17381134 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in decreased expression of EPHX2 mRNA | 27339419 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased expression of EPHX2 mRNA | 17484886 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride affects the expression of EPHX2 mRNA | 12734012 |
| D002259 | Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone | Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone results in decreased expression of EPHX2 mRNA | 16039398 |
| C026690 | cerous chloride | cerous chloride affects the expression of EPHX2 mRNA | 28954213 |
| C026690 | cerous chloride | [cerous chloride co-treated with lanthanum chloride] results in increased expression of EPHX2 mRNA | 28954213 |
| C031294 | chlorobenzene | chlorobenzene results in decreased expression of EPHX2 mRNA | 19800902 |
| D020245 | p-Chloromercuribenzoic Acid | "[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EPHX2 mRNA" | 27188386 |
| D020245 | p-Chloromercuribenzoic Acid | p-Chloromercuribenzoic Acid results in decreased expression of EPHX2 mRNA | 26272509 |
| C002415 | cholesterol alpha-oxide | cholesterol alpha-oxide inhibits the reaction [EPHX2 protein results in increased metabolism of stilbene oxide analog] | 2043152 |
| D002922 | Ciguatoxins | Ciguatoxins affects the expression of EPHX2 mRNA | 18353800 |
| D002994 | Clofibrate | [Clofibrate co-treated with Acetaminophen] affects the expression of EPHX2 mRNA | 17585979 |
| D002994 | Clofibrate | Clofibrate results in increased activity of EPHX2 protein | 3621371 |
| D002994 | Clofibrate | Clofibrate results in increased expression of EPHX2 mRNA | 17585979 |
| D002994 | Clofibrate | Clofibrate results in increased expression of EPHX2 protein | 3318844|3621371| |
| D002994 | Clofibrate | PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of EPHX2 mRNA] | 17585979 |
| D002994 | Clofibrate | Clofibrate results in increased expression of EPHX2 mRNA | 11328961|1503359 |
| D002994 | Clofibrate | Clofibrate results in increased expression of EPHX2 protein | 16470657|3768023 |
| D003300 | Copper | Copper results in decreased expression of EPHX2 mRNA | 22465980 |
| D019327 | Copper Sulfate | Copper Sulfate results in decreased expression of EPHX2 mRNA | 19549813 |
| D003314 | Corn Oil | Corn Oil affects the expression of EPHX2 mRNA | 16360708 |
| D016572 | Cyclosporine | Cyclosporine results in decreased expression of EPHX2 mRNA | 20106945|2383089 |
| D016572 | Cyclosporine | Cyclosporine affects the expression of EPHX2 mRNA | 19770486 |
| D016572 | Cyclosporine | Cyclosporine results in decreased expression of EPHX2 mRNA | 23830897 |
| C093628 | cyproconazole | cyproconazole results in decreased expression of EPHX2 mRNA | 22334560 |
| D015084 | 2,4-Dichlorophenoxyacetic Acid | "2,4-Dichlorophenoxyacetic Acid results in increased activity of EPHX2 protein" | 1755024|3032197 |
| C010902 | decabromobiphenyl ether | decabromobiphenyl ether results in increased expression of EPHX2 mRNA | 23640034 |
| D015230 | Prostaglandin D2 | EPHX2 gene mutant form promotes the reaction [Aspirin inhibits the reaction [Lipopolysaccharides results in increased abundance of Prostaglandin D2]] | 19896470 |
| D003907 | Dexamethasone | Dexamethasone inhibits the reaction [RX3 gene mutant form affects the expression of EPHX2 mRNA] | 27941970 |
| D003907 | Dexamethasone | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of EPHX2 mRNA | 16054899 |
| D003907 | Dexamethasone | [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of EPHX2 mRNA] | 16054899 |
| D003907 | Dexamethasone | Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of EPHX2 mRNA] | 16054899 |
| D003907 | Dexamethasone | Dexamethasone results in increased expression of EPHX2 mRNA | 14618091 |
| D002945 | Cisplatin | [Cisplatin co-treated with jinfukang] results in increased expression of EPHX2 mRNA | 27392435 |
| D002945 | Cisplatin | Cisplatin results in increased expression of EPHX2 mRNA | 27392435 |
| D002945 | Cisplatin | Cisplatin results in decreased expression of EPHX2 mRNA | 26165641 |
| D002945 | Cisplatin | Cisplatin results in decreased expression of EPHX2 protein | 26165641 |
| D002945 | Cisplatin | phenylmethylpyrazolone inhibits the reaction [Cisplatin results in decreased expression of EPHX2 protein] | 26165641 |
| C121718 | dicyclanil | dicyclanil results in increased expression of EPHX2 mRNA | 15664270 |
| D004026 | Dieldrin | Dieldrin promotes the reaction [EPHX2 protein results in increased metabolism of stilbene oxide] | 2043152 |
| D004041 | Dietary Fats | 1-(1-methanesulfonylpiperidin-4-yl)-3-(4-trifluoromethoxyphenyl)urea inhibits the reaction [Dietary Fats inhibits the reaction [EPHX2 gene mutant form results in decreased phosphorylation of EIF2AK3 protein]] | 23576437 |
| D004041 | Dietary Fats | "3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of EPHX2 mRNA]" | 19467301 |
| D004041 | Dietary Fats | [Dietary Fats co-treated with Dietary Sucrose] results in increased expression of EPHX2 mRNA | 28433925 |
| D004041 | Dietary Fats | Dietary Fats inhibits the reaction [EPHX2 gene mutant form results in decreased phosphorylation of ATF6 protein] | 23576437 |
| D004041 | Dietary Fats | Dietary Fats inhibits the reaction [EPHX2 gene mutant form results in decreased phosphorylation of EIF2AK3 protein] | 23576437 |
| D004041 | Dietary Fats | Dietary Fats inhibits the reaction [EPHX2 gene mutant form results in decreased phosphorylation of EIF2S1 protein] | 23576437 |
| D004041 | Dietary Fats | Dietary Fats results in increased expression of EPHX2 mRNA | 19467301 |
| D004041 | Dietary Fats | Dietary Fats results in increased expression of EPHX2 protein | 23576437 |
| D004041 | Dietary Fats | EPHX2 gene mutant form inhibits the reaction [Dietary Fats results in decreased expression of PPP1R15A protein] | 23576437 |
| D019422 | Dietary Sucrose | [Dietary Fats co-treated with Dietary Sucrose] results in increased expression of EPHX2 mRNA | 28433925 |
| D004051 | Diethylhexyl Phthalate | Diethylhexyl Phthalate results in increased expression of EPHX2 mRNA | 19850644 |
| D004051 | Diethylhexyl Phthalate | Diethylhexyl Phthalate results in increased expression of EPHX2 protein | 3318844|3621371 |
| D004051 | Diethylhexyl Phthalate | PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of EPHX2 mRNA] | 19850644 |
| D004051 | Diethylhexyl Phthalate | "[Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in increased expression of EPHX2 mRNA" | 28433925 |
| D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of EPHX2 mRNA | 18544905 |
| D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with kojic acid] results in increased expression of EPHX2 mRNA | 18544905 |
| D015127 | 9,10-Dimethyl-1,2-benzanthracene | "9,10-Dimethyl-1,2-benzanthracene results in decreased expression of EPHX2 mRNA" | 22485181 |
| C051904 | dinophysistoxin 1 | dinophysistoxin 1 results in decreased expression of EPHX2 mRNA | 28939011 |
| D004221 | Disulfiram | Disulfiram results in decreased expression of EPHX2 mRNA | 20530235 |
| D004237 | Diuron | Diuron results in increased expression of EPHX2 mRNA | 21551480 |
| D004317 | Doxorubicin | Doxorubicin results in increased expression of EPHX2 mRNA | 19796650 |
| C042986 | ebselen | ebselen binds to and results in decreased activity of EPHX2 protein | 23219563 |
| C045533 | eicosa-5,11,14-trienoic acid | "[Arsenites results in increased expression of and results in increased activity of EPHX2 protein] which results in increased abundance of eicosa-5,11,14-trienoic acid analog" | 22680237 |
| D015777 | Eicosanoids | EPHX2 gene mutant form results in decreased metabolism of Eicosanoids | 21832210 |
| D052244 | Endocrine Disruptors | Endocrine Disruptors results in decreased expression of EPHX2 mRNA | 25198161 |
| C109476 | epoxiconazole | epoxiconazole results in decreased expression of EPHX2 mRNA | 22334560 |
| D004852 | Epoxy Compounds | EPHX2 gene mutant form results in decreased metabolism of Epoxy Compounds | 21832210 |
| D000431 | Ethanol | [Fish Oils co-treated with Ethanol] results in increased expression of EPHX2 mRNA | 17347304 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in increased expression of EPHX2 protein | 20227414 |
| D005001 | Ethionine | Ethionine results in decreased expression of EPHX2 protein | 3621371 |
| D019830 | Adenosine-5'-(N-ethylcarboxamide) | EPHX2 gene mutant form results in increased susceptibility to Adenosine-5'-(N-ethylcarboxamide) | 23152114 |
| C100167 | ethylphenylepoxygeranyl ether | ethylphenylepoxygeranyl ether promotes the reaction [EPHX2 protein results in increased metabolism of stilbene oxide] | 2043152 |
| C047360 | felbamate | felbamate results in decreased expression of EPHX2 mRNA | 17381134 |
| D011345 | Fenofibrate | Fenofibrate affects the expression of EPHX2 mRNA | 20801182 |
| C017690 | fenvalerate | fenvalerate metabolite results in increased activity of EPHX2 protein | 10630566 |
| D005395 | Fish Oils | [Fish Oils co-treated with Ethanol] results in increased expression of EPHX2 mRNA | 17347304 |
| D005419 | Flavonoids | Flavonoids results in decreased expression of EPHX2 mRNA | 18035473 |
| D005485 | Flutamide | Flutamide results in decreased expression of EPHX2 mRNA | 24136188 |
| C039281 | furan | furan results in decreased expression of EPHX2 mRNA | 20194422 |
| D019833 | Genistein | ESR2 promotes the reaction [Genistein results in increased expression of EPHX2 protein] | 20884965 |
| D019833 | Genistein | Genistein results in increased expression of EPHX2 protein | 20884965 |
| D005839 | Gentamicins | Gentamicins results in decreased expression of EPHX2 protein | 22061828 |
| D019695 | Glycyrrhizic Acid | Glycyrrhizic Acid inhibits the reaction [Benzo(a)pyrene results in decreased activity of EPHX2 protein] | 22051199 |
| C453899 | GW 7647 | GW 7647 results in decreased activity of EPHX2 protein | 15798002 |
| C010178 | heliotrine | heliotrine results in decreased expression of EPHX2 mRNA | 26100227 |
| D006534 | Heptachlor Epoxide | Heptachlor Epoxide inhibits the reaction [EPHX2 protein results in increased metabolism of stilbene oxide analog] | 2043152 |
| D006534 | Heptachlor Epoxide | Heptachlor Epoxide promotes the reaction [EPHX2 protein results in increased metabolism of stilbene oxide] | 2043152 |
| D019377 | 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid | "12-Hydroxy-5,8,10,14-eicosatetraenoic Acid results in increased activity of EPHX2 protein" | 25600587 |
| D006581 | Hexachlorobenzene | Hexachlorobenzene results in decreased expression of EPHX2 mRNA | 15159207 |
| D017313 | Fenretinide | Fenretinide results in increased expression of EPHX2 mRNA | 28973697 |
| D006843 | Hydrocarbons, Chlorinated | "Hydrocarbons, Chlorinated results in increased activity of EPHX2 protein" | 3621371 |
| D006843 | Hydrocarbons, Chlorinated | "Hydrocarbons, Chlorinated results in increased expression of EPHX2 protein" | 3621371 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide affects the expression of EPHX2 mRNA | 20044591 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in increased expression of EPHX2 mRNA | 14729362 |
| C474021 | indirubin-3'-monoxime | indirubin-3'-monoxime results in decreased expression of EPHX2 mRNA | 18958680 |
| D015056 | 1-Methyl-3-isobutylxanthine | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of EPHX2 mRNA | 16054899 |
| D015056 | 1-Methyl-3-isobutylxanthine | [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of EPHX2 mRNA] | 16054899 |
| D015056 | 1-Methyl-3-isobutylxanthine | Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of EPHX2 mRNA] | 16054899 |
| C544151 | jinfukang | [Cisplatin co-treated with jinfukang] results in increased expression of EPHX2 mRNA | 27392435 |
| C544151 | jinfukang | jinfukang results in increased expression of EPHX2 mRNA | 27392435 |
| C410337 | K 7174 | K 7174 results in decreased expression of EPHX2 mRNA | 24086573 |
| C011890 | kojic acid | [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of EPHX2 mRNA | 18544905 |
| C011890 | kojic acid | [Diethylnitrosamine co-treated with kojic acid] results in increased expression of EPHX2 mRNA | 18544905 |
| D007810 | Lanosterol | Lanosterol analog inhibits the reaction [EPHX2 protein results in increased metabolism of stilbene oxide analog] | 2043152 |
| C028521 | lanthanum chloride | [cerous chloride co-treated with lanthanum chloride] results in increased expression of EPHX2 mRNA | 28954213 |
| C008261 | lead acetate | lead acetate affects the expression of EPHX2 mRNA | 21864555|2264161 |
| C045463 | leflunomide | leflunomide results in decreased expression of EPHX2 mRNA | 28988120 |
| C001546 | limonin | limonin inhibits the reaction [EPHX2 protein results in increased metabolism of stilbene oxide analog] | 2043152 |
| C002385 | linsidomine | linsidomine results in increased oxidation of EPHX2 protein | 28086193 |
| C482199 | lipopolysaccharide, E coli O55-B5 | "lipopolysaccharide, E coli O55-B5 results in decreased expression of EPHX2 mRNA" | 23939143 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with resveratrol] results in increased expression of EPHX2 mRNA | 26667767 |
| D008070 | Lipopolysaccharides | Aspirin promotes the reaction [EPHX2 gene mutant form results in decreased susceptibility to Lipopolysaccharides] | 19896470 |
| D008070 | Lipopolysaccharides | EPHX2 gene mutant form affects the reaction [Lipopolysaccharides results in increased abundance of Dinoprostone] | 19896470 |
| D008070 | Lipopolysaccharides | "EPHX2 gene mutant form inhibits the reaction [Lipopolysaccharides results in increased abundance of 11,12-dihydroxyeicosatrienoic acid]" | 19896470 |
| D008070 | Lipopolysaccharides | "EPHX2 gene mutant form inhibits the reaction [Lipopolysaccharides results in increased abundance of 14,15-dihydroxyeicosatrienoic acid]" | 19896470 |
| D008070 | Lipopolysaccharides | EPHX2 gene mutant form inhibits the reaction [Lipopolysaccharides results in increased expression of ALOX5 protein] | 19896470 |
| D008070 | Lipopolysaccharides | EPHX2 gene mutant form promotes the reaction [Aspirin inhibits the reaction [Lipopolysaccharides results in increased abundance of Dinoprostone]] | 19896470 |
| D008070 | Lipopolysaccharides | EPHX2 gene mutant form promotes the reaction [Aspirin inhibits the reaction [Lipopolysaccharides results in increased abundance of Prostaglandin D2]] | 19896470 |
| D008070 | Lipopolysaccharides | "EPHX2 gene mutant form promotes the reaction [[Lipopolysaccharides co-treated with Aspirin] results in decreased abundance of 11,12-dihydroxyeicosatrienoic acid]" | 19896470 |
| D008070 | Lipopolysaccharides | "EPHX2 gene mutant form promotes the reaction [[Lipopolysaccharides co-treated with Aspirin] results in decreased abundance of 14,15-dihydroxyeicosatrienoic acid]" | 19896470 |
| D008070 | Lipopolysaccharides | "EPHX2 gene mutant form promotes the reaction [[Lipopolysaccharides co-treated with MK-886] results in decreased abundance of 11,12-dihydroxyeicosatrienoic acid]" | 19896470 |
| D008070 | Lipopolysaccharides | "EPHX2 gene mutant form promotes the reaction [[Lipopolysaccharides co-treated with MK-886] results in decreased abundance of 14,15-dihydroxyeicosatrienoic acid]" | 19896470 |
| D008070 | Lipopolysaccharides | "EPHX2 gene mutant form promotes the reaction [MK-886 inhibits the reaction [Lipopolysaccharides results in increased abundance of 5-hydroxy-6,8,11,14-eicosatetraenoic acid]]" | 19896470 |
| D008070 | Lipopolysaccharides | EPHX2 gene mutant form promotes the reaction [MK-886 inhibits the reaction [Lipopolysaccharides results in increased expression of ALOX5 protein]] | 19896470 |
| D008070 | Lipopolysaccharides | EPHX2 gene mutant form results in decreased susceptibility to Lipopolysaccharides | 19896470 |
| D008070 | Lipopolysaccharides | MK-886 promotes the reaction [EPHX2 gene mutant form results in decreased susceptibility to Lipopolysaccharides] | 19896470 |
| C008340 | mecoprop | mecoprop results in increased activity of EPHX2 protein | 1755024 |
| D008627 | Mercuric Chloride | Mercuric Chloride results in increased expression of and results in increased activity of EPHX2 protein | 24472606 |
| D008627 | Mercuric Chloride | "[Mercuric Chloride results in increased expression of and results in increased activity of EPHX2 protein] which results in decreased abundance of 11,12-epoxy-5,8,14-eicosatrienoic acid" | 24472606 |
| D008627 | Mercuric Chloride | "[Mercuric Chloride results in increased expression of and results in increased activity of EPHX2 protein] which results in decreased abundance of 14,15-epoxy-5,8,11-eicosatrienoic acid" | 24472606 |
| D008748 | Methylcholanthrene | Methylcholanthrene results in decreased activity of EPHX2 protein | 3621371 |
| D008748 | Methylcholanthrene | Methylcholanthrene results in increased activity of EPHX2 protein | 19889059 |
| D008748 | Methylcholanthrene | Methylcholanthrene results in increased expression of EPHX2 mRNA | 19889059 |
| D008748 | Methylcholanthrene | Methylcholanthrene results in increased expression of EPHX2 protein | 19889059 |
| C004925 | methylmercuric chloride | methylmercuric chloride results in increased expression of EPHX2 mRNA | 23103053 |
| C004925 | methylmercuric chloride | methylmercuric chloride results in decreased expression of EPHX2 mRNA | 28001369 |
| D008741 | Methyl Methanesulfonate | Methyl Methanesulfonate results in decreased expression of EPHX2 mRNA | 26011545 |
| D015741 | Metribolone | Metribolone results in increased expression of EPHX2 protein | 17152098 |
| C060893 | MK-886 | "EPHX2 gene mutant form promotes the reaction [[Lipopolysaccharides co-treated with MK-886] results in decreased abundance of 11,12-dihydroxyeicosatrienoic acid]" | 19896470 |
| C060893 | MK-886 | "EPHX2 gene mutant form promotes the reaction [[Lipopolysaccharides co-treated with MK-886] results in decreased abundance of 14,15-dihydroxyeicosatrienoic acid]" | 19896470 |
| C060893 | MK-886 | "EPHX2 gene mutant form promotes the reaction [MK-886 inhibits the reaction [Lipopolysaccharides results in increased abundance of 5-hydroxy-6,8,11,14-eicosatetraenoic acid]]" | 19896470 |
| C060893 | MK-886 | EPHX2 gene mutant form promotes the reaction [MK-886 inhibits the reaction [Lipopolysaccharides results in increased expression of ALOX5 protein]] | 19896470 |
| C060893 | MK-886 | MK-886 promotes the reaction [EPHX2 gene mutant form results in decreased susceptibility to Lipopolysaccharides] | 19896470 |
| C016599 | mono-(2-ethylhexyl)phthalate | mono-(2-ethylhexyl)phthalate results in decreased expression of EPHX2 mRNA | 22401849 |
| D009020 | Morphine | Morphine results in increased expression of EPHX2 mRNA | 21178816 |
| C500085 | muraglitazar | muraglitazar results in increased expression of EPHX2 mRNA | 21515302 |
| C031721 | naphthalene | naphthalene results in increased expression of EPHX2 mRNA | 20500019 |
| D015058 | 1-Naphthylisothiocyanate | 1-Naphthylisothiocyanate results in decreased activity of EPHX2 protein | 3621371 |
| D009532 | Nickel | Nickel results in decreased expression of EPHX2 mRNA | 24768652 |
| C059405 | nomilin | nomilin inhibits the reaction [EPHX2 protein results in increased metabolism of stilbene oxide analog] | 2043152 |
| D010098 | Oxycodone | Oxycodone affects the expression of EPHX2 mRNA | 20487198 |
| D010126 | Ozone | Ozone results in increased expression of EPHX2 mRNA | 27206323 |
| D017239 | Paclitaxel | Paclitaxel results in increased expression of EPHX2 mRNA | 18754875 |
| D010168 | Palmitates | Palmitates results in increased expression of EPHX2 protein | 23576437 |
| D010168 | Palmitates | Palmitates results in increased expression of EPHX2 protein | 23576437 |
| C076994 | perfluorooctane sulfonic acid | perfluorooctane sulfonic acid affects the expression of EPHX2 mRNA | 19429403 |
| C076994 | perfluorooctane sulfonic acid | perfluorooctane sulfonic acid results in increased expression of EPHX2 mRNA | 20936131 |
| C076994 | perfluorooctane sulfonic acid | perfluorooctane sulfonic acid results in increased expression of EPHX2 mRNA | 19162173 |
| C023036 | perfluorooctanoic acid | perfluorooctanoic acid affects the expression of EPHX2 mRNA | 19429403 |
| C023036 | perfluorooctanoic acid | perfluorooctanoic acid results in increased expression of EPHX2 mRNA | 17681415|1846767 |
| C023036 | perfluorooctanoic acid | PPARA protein promotes the reaction [perfluorooctanoic acid results in increased expression of EPHX2 mRNA] | 18467677|2093613 |
| C023036 | perfluorooctanoic acid | perfluorooctanoic acid results in decreased activity of EPHX2 protein | 10528994 |
| C023036 | perfluorooctanoic acid | perfluorooctanoic acid results in increased expression of EPHX2 mRNA | 16221955|1916217 |
| D015232 | Dinoprostone | EPHX2 gene mutant form affects the reaction [Lipopolysaccharides results in increased abundance of Dinoprostone] | 19896470 |
| D015232 | Dinoprostone | EPHX2 gene mutant form promotes the reaction [Aspirin inhibits the reaction [Lipopolysaccharides results in increased abundance of Dinoprostone]] | 19896470 |
| D010634 | Phenobarbital | Phenobarbital results in decreased expression of EPHX2 mRNA | 17381134|1916217 |
| D010656 | Phenylephrine | Phenylephrine results in decreased expression of EPHX2 mRNA | 18158353 |
| D010662 | Phenylmercuric Acetate | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EPHX2 mRNA" | 27188386 |
| D010662 | Phenylmercuric Acetate | Phenylmercuric Acetate results in decreased expression of EPHX2 mRNA | 26272509 |
| C005435 | phenylmethylpyrazolone | phenylmethylpyrazolone inhibits the reaction [Cisplatin results in decreased expression of EPHX2 protein] | 26165641 |
| D010672 | Phenytoin | Phenytoin results in decreased expression of EPHX2 mRNA | 17381134 |
| C006253 | pirinixic acid | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of EPHX2 mRNA | 19710929 |
| C006253 | pirinixic acid | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of EPHX2 mRNA | 19710929 |
| C006253 | pirinixic acid | pirinixic acid results in increased expression of EPHX2 mRNA | 15375163|1742611 |
| C006253 | pirinixic acid | PPARA protein promotes the reaction [pirinixic acid results in increased expression of EPHX2 mRNA] | 18467677|2005976 |
| C006253 | pirinixic acid | pirinixic acid results in increased expression of EPHX2 mRNA | 19162173|2248451 |
| D017035 | Pravastatin | Pravastatin results in decreased expression of EPHX2 mRNA | 27225895 |
| D017035 | Pravastatin | Pravastatin results in decreased expression of EPHX2 mRNA | 27225895 |
| D011285 | Pregnenolone Carbonitrile | Pregnenolone Carbonitrile results in decreased expression of EPHX2 mRNA | 27413110 |
| D011374 | Progesterone | Progesterone results in decreased expression of EPHX2 mRNA | 23018184 |
| C045950 | propiconazole | propiconazole results in decreased expression of EPHX2 mRNA | 22334560 |
| C010423 | pyrithione zinc | pyrithione zinc results in increased expression of EPHX2 mRNA | 21424779 |
| D011763 | Pyrrolizidine Alkaloids | Pyrrolizidine Alkaloids results in decreased expression of EPHX2 mRNA | 26100227 |
| D011794 | Quercetin | [Quercetin co-treated with Ascorbic Acid] results in decreased expression of EPHX2 mRNA | 17639512 |
| D011794 | Quercetin | Quercetin results in decreased activity of EPHX2 protein | 3621371 |
| D011794 | Quercetin | Quercetin results in decreased expression of EPHX2 mRNA | 17103110 |
| D011794 | Quercetin | Quercetin results in increased expression of EPHX2 mRNA | 18095365 |
| C059514 | resveratrol | [Lipopolysaccharides co-treated with resveratrol] results in increased expression of EPHX2 mRNA | 26667767 |
| C059514 | resveratrol | resveratrol results in increased expression of EPHX2 mRNA | 25436977 |
| C488333 | Ro 65-7199 | Ro 65-7199 affects the expression of EPHX2 mRNA | 14610520 |
| C089730 | rosiglitazone | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of EPHX2 mRNA | 16054899 |
| C089730 | rosiglitazone | rosiglitazone results in increased expression of EPHX2 mRNA | 15520860 |
| C089730 | rosiglitazone | [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of EPHX2 mRNA] | 16054899 |
| C089730 | rosiglitazone | Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of EPHX2 mRNA] | 16054899 |
| C089730 | rosiglitazone | rosiglitazone results in increased expression of EPHX2 mRNA | 21515302 |
| D012643 | Selenium | Selenium results in increased expression of EPHX2 mRNA | 19244175 |
| C009237 | senecionine | senecionine results in decreased expression of EPHX2 mRNA | 26100227 |
| C009238 | senkirkine | senkirkine results in decreased expression of EPHX2 mRNA | 26100227 |
| D012822 | Silicon Dioxide | Silicon Dioxide analog results in decreased expression of EPHX2 mRNA | 25895662 |
| C009277 | sodium arsenate | sodium arsenate results in increased expression of EPHX2 mRNA | 23922661 |
| C017947 | sodium arsenite | sodium arsenite results in decreased expression of EPHX2 protein | 23570992 |
| C017947 | sodium arsenite | CARM1 mutant form inhibits the reaction [sodium arsenite results in decreased expression of EPHX2 mRNA] | 23699174 |
| C017947 | sodium arsenite | PRMT1 mutant form inhibits the reaction [sodium arsenite results in decreased expression of EPHX2 mRNA] | 23699174 |
| C017947 | sodium arsenite | sodium arsenite affects the methylation of EPHX2 gene | 28589171 |
| C017947 | sodium arsenite | sodium arsenite results in decreased expression of EPHX2 mRNA | 23699174 |
| C017947 | sodium arsenite | sodium arsenite results in increased expression of EPHX2 mRNA | 28229933 |
| C016104 | sodium bichromate | sodium bichromate results in increased expression of EPHX2 mRNA | 12325037 |
| D015086 | 2,6-Dichloroindophenol | "[2,6-Dichloroindophenol co-treated with NQO1 protein polymorphism] results in increased expression of EPHX2 mRNA" | 21034357 |
| D012969 | Sodium Fluoride | Sodium Fluoride results in decreased expression of EPHX2 mRNA | 27862939 |
| D053260 | Soot | Soot results in decreased expression of EPHX2 mRNA | 21914721 |
| C075117 | squalestatin 1 | squalestatin 1 affects the expression of EPHX2 mRNA | 27225895 |
| C075117 | squalestatin 1 | squalestatin 1 results in increased expression of EPHX2 mRNA | 27225895 |
| C025906 | stilbene oxide | "16 alpha,17-epoxyprogesterone inhibits the reaction [EPHX2 protein results in increased metabolism of stilbene oxide analog]" | 2043152 |
| C025906 | stilbene oxide | cholesterol alpha-oxide inhibits the reaction [EPHX2 protein results in increased metabolism of stilbene oxide analog] | 2043152 |
| C025906 | stilbene oxide | Dieldrin promotes the reaction [EPHX2 protein results in increased metabolism of stilbene oxide] | 2043152 |
| C025906 | stilbene oxide | EPHX2 protein results in increased metabolism of stilbene oxide | 2043152 |
| C025906 | stilbene oxide | EPHX2 protein results in increased metabolism of stilbene oxide analog | 2043152 |
| C025906 | stilbene oxide | ethylphenylepoxygeranyl ether promotes the reaction [EPHX2 protein results in increased metabolism of stilbene oxide] | 2043152 |
| C025906 | stilbene oxide | Heptachlor Epoxide inhibits the reaction [EPHX2 protein results in increased metabolism of stilbene oxide analog] | 2043152 |
| C025906 | stilbene oxide | Heptachlor Epoxide promotes the reaction [EPHX2 protein results in increased metabolism of stilbene oxide] | 2043152 |
| C025906 | stilbene oxide | Lanosterol analog inhibits the reaction [EPHX2 protein results in increased metabolism of stilbene oxide analog] | 2043152 |
| C025906 | stilbene oxide | limonin inhibits the reaction [EPHX2 protein results in increased metabolism of stilbene oxide analog] | 2043152 |
| C025906 | stilbene oxide | nomilin inhibits the reaction [EPHX2 protein results in increased metabolism of stilbene oxide analog] | 2043152 |
| C025906 | stilbene oxide | tridiphane promotes the reaction [EPHX2 protein results in increased metabolism of stilbene oxide] | 2043152 |
| C025906 | stilbene oxide | tridiphane promotes the reaction [EPHX2 protein results in increased metabolism of stilbene oxide analog] | 2043152 |
| D013311 | Streptozocin | EPHX2 gene mutant form inhibits the reaction [Streptozocin results in increased activity of RELA protein] | 21832210 |
| D013311 | Streptozocin | EPHX2 gene mutant form inhibits the reaction [Streptozocin results in increased secretion of CCL2 protein] | 21832210 |
| D013311 | Streptozocin | EPHX2 gene mutant form results in decreased susceptibility to Streptozocin | 21832210 |
| D013311 | Streptozocin | Streptozocin results in increased expression of EPHX2 protein | 23611540 |
| C458508 | T 0070907 | EPHX2 gene results in decreased susceptibility to T 0070907 | 23152114 |
| C458508 | T 0070907 | T 0070907 inhibits the reaction [EPHX2 gene mutant form results in increased susceptibility to 2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine] | 23152114 |
| D015085 | 2,4,5-Trichlorophenoxyacetic Acid | "2,4,5-Trichlorophenoxyacetic Acid results in increased expression of and results in increased activity of EPHX2 protein" | 3032197 |
| C501413 | tesaglitazar | tesaglitazar results in increased expression of EPHX2 mRNA | 21515302 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of EPHX2 mRNA | 16039398|2129612 |
| D013749 | Tetrachlorodibenzodioxin | "[Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in increased expression of EPHX2 mRNA" | 28433925 |
| D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of EPHX2 mRNA] | 16054899 |
| D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin co-treated with EGF protein] results in decreased expression of EPHX2 mRNA | 16054899 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of EPHX2 mRNA] | 16054899 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of EPHX2 mRNA | 16054899 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of EPHX2 mRNA | 22298810 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of EPHX2 mRNA | 21215274 |
| D013752 | Tetracycline | Tetracycline results in decreased expression of EPHX2 mRNA | 24489787 |
| D013893 | Thiram | Thiram results in decreased expression of EPHX2 mRNA | 20530235 |
| C009495 | titanium dioxide | titanium dioxide results in decreased expression of EPHX2 mRNA | 23557971 |
| C009495 | titanium dioxide | titanium dioxide results in increased expression of EPHX2 mRNA | 23131501 |
| D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution affects the expression of EPHX2 mRNA | 20133372 |
| D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution results in increased expression of EPHX2 mRNA | 15289447 |
| D014212 | Tretinoin | Tretinoin results in decreased expression of EPHX2 mRNA | 20530235 |
| C011559 | tributyltin | tributyltin results in decreased expression of EPHX2 mRNA | 29191790 |
| D014241 | Trichloroethylene | PPARA protein inhibits the reaction [Trichloroethylene results in increased expression of EPHX2 protein] | 15363585 |
| D014241 | Trichloroethylene | Trichloroethylene results in increased expression of EPHX2 mRNA | 15363585 |
| C009540 | triclocarban | triclocarban results in decreased activity of EPHX2 protein | 21741984 |
| C051460 | tridiphane | tridiphane promotes the reaction [EPHX2 protein results in increased metabolism of stilbene oxide] | 2043152 |
| C051460 | tridiphane | tridiphane promotes the reaction [EPHX2 protein results in increased metabolism of stilbene oxide analog] | 2043152 |
| C015559 | trimellitic anhydride | trimellitic anhydride results in decreased expression of EPHX2 mRNA | 19042947 |
| C016805 | tris(1,3-dichloro-2-propyl)phosphate | "tris(1,3-dichloro-2-propyl)phosphate results in decreased expression of EPHX2 mRNA" | 26179874 |
| C057693 | troglitazone | troglitazone results in increased expression of EPHX2 mRNA | 19631733 |
| C057693 | troglitazone | troglitazone results in increased expression of EPHX2 mRNA | 28973697 |
| C057693 | troglitazone | troglitazone results in increased expression of EPHX2 mRNA | 21515302 |
| C057693 | troglitazone | troglitazone results in increased expression of EPHX2 protein | 21315101 |
| C112106 | UAB 30 | UAB 30 analog results in increased expression of EPHX2 mRNA | 23292798 |
| D014508 | Urea | Urea analog results in decreased activity of EPHX2 protein | 15798002 |
| D014520 | Urethane | Urethane results in decreased expression of EPHX2 mRNA | 28818685 |
| D014635 | Valproic Acid | Valproic Acid results in decreased expression of EPHX2 mRNA | 23179753|2915479 |
| D014635 | Valproic Acid | Valproic Acid results in decreased methylation of EPHX2 gene | 29154799 |
| D014635 | Valproic Acid | Valproic Acid results in decreased expression of EPHX2 mRNA | 17381134 |
| D001335 | Vehicle Emissions | Vehicle Emissions results in increased methylation of EPHX2 gene | 25560391 |
| C025643 | vinclozolin | vinclozolin results in decreased expression of EPHX2 mRNA | 20566332 |
| D014874 | Water Pollutants, Chemical | "Water Pollutants, Chemical results in decreased expression of EPHX2 mRNA" | 25198161 |
| D014874 | Water Pollutants, Chemical | "Water Pollutants, Chemical results in increased expression of EPHX2 mRNA" | 23246600 |
| C088658 | zoledronic acid | zoledronic acid results in decreased expression of EPHX2 mRNA | 24714768 |
| C088658 | zoledronic acid | zoledronic acid results in increased expression of EPHX2 protein | 28871336 |